Paper41575672
Anti-obesity Pharmacotherapy for Transplant Recipients.
Haugen CE and 1 other. Curr Atheroscler Rep, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Anti-obesity Pharmacotherapy for Transplant Recipients. Papers, record 41575672. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41575672
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Obesity | Major topic |
| Kidney Transplantation | Major topic |
| Anti-Obesity Agents | Major topic |
| Liver Transplantation | Major topic |
| Transplant Recipients | Major topic |
| Humans |
Source PubMed
References103
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39283612 | GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. | JAMA Intern Med | 2024 | https://conductscience.org/library/papers/39283612 | PubMed |
| 2 | 38993868 | Modern glucose-lowering drugs in liver transplant recipients: improvement in weight, glycemic control, and potentially allograft steatosis. | Front Transplant | 2023 | https://conductscience.org/library/papers/38993868 | PubMed |
| 3 | 39919868 | Nutrient-Stimulating Hormone-Based Therapies for Obesity. | Endocrinol Metab Clin North Am | 2025 | https://conductscience.org/library/papers/39919868 | PubMed |
| 4 | 9683204 | Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group. | Lancet | 1998 | https://conductscience.org/library/papers/9683204 | PubMed |
| 5 | 31835505 | Weight Gain and De Novo Metabolic Disorders after Liver Transplantation. | Nutrients | 2019 | https://conductscience.org/library/papers/31835505 | PubMed |
| 6 | 39025300 | The Use of Semaglutide in Patients With Renal Failure-A Retrospective Cohort Study. | Endocr Pract | 2024 | https://conductscience.org/library/papers/39025300 | PubMed |
| 7 | 35042452 | Recipient obesity as a risk factor in kidney transplantation. | BMC Nephrol | 2022 | https://conductscience.org/library/papers/35042452 | PubMed |
| 8 | 30325004 | National Trends in Liver Transplantation in Older Adults. | J Am Geriatr Soc | 2018 | https://conductscience.org/library/papers/30325004 | PubMed |
| 9 | 29026064 | The Effect of Recipient Body Mass Index and Its Extremes on Survival and Graft Vascular and Biliary Complications After Liver Transplantation: A Single Center Retrospective Study. | Ann Transplant | 2017 | https://conductscience.org/library/papers/29026064 | PubMed |
| 10 | 17081230 | Orlistat treatment is safe in overweight and obese liver transplant recipients: a prospective, open label trial. | Transpl Int | 2006 | https://conductscience.org/library/papers/17081230 | PubMed |
| 11 | 18497684 | Predictive factors for posttransplant diabetes mellitus within one-year of liver transplantation. | Transplantation | 2008 | https://conductscience.org/library/papers/18497684 | PubMed |
| 12 | 32301874 | KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation. | Transplantation | 2020 | https://conductscience.org/library/papers/32301874 | PubMed |
| 13 | 12087008 | Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin. | Diabetes Care | 2002 | https://conductscience.org/library/papers/12087008 | PubMed |
| 14 | 20673995 | Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. | Lancet | 2010 | https://conductscience.org/library/papers/20673995 | PubMed |
| 15 | 23744721 | Comparable graft and patient survival in lean and obese liver transplant recipients. | Liver Transpl | 2013 | https://conductscience.org/library/papers/23744721 | PubMed |
| 16 | 9702435 | Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study. | Diabetes Care | 1998 | https://conductscience.org/library/papers/9702435 | PubMed |
| 17 | 37119856 | Recipient race modifies the association between obesity and long-term graft outcomes after kidney transplantation. | Am J Transplant | 2023 | https://conductscience.org/library/papers/37119856 | PubMed |
| 18 | 10693734 | Orlistat in the long-term treatment of obesity in primary care settings. | Arch Fam Med | 2000 | https://conductscience.org/library/papers/10693734 | PubMed |
| 19 | 16802443 | Anti-obesity therapies. | Nat Rev Drug Discov | 2006 | https://conductscience.org/library/papers/16802443 | PubMed |
| 20 | 34714569 | A meta-analysis of the cumulative incidence, risk factors, and clinical outcomes associated with chronic kidney disease after liver transplantation. | Transpl Int | 2021 | https://conductscience.org/library/papers/34714569 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42074719 | Insulin Resistance and Atherogenic Dyslipidemia Drive Cardiac Remodeling and Cardiovascular Events After Kidney Transplantation. | J Clin Med | 2026 | https://conductscience.org/library/papers/42074719 |
Source PubMed
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GIP | 2695 | PubTator's text mining | https://conductscience.org/library/genes/2695 | NCBI Gene |
| GLP1R | 2740 | PubTator's text mining | https://conductscience.org/library/genes/2740 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41575672
GET https://conductscience.org/api/papers/v1/41575672/references?page=2